Multicenter Study of the Avenue L Interbody Spinal Fusion System Using VerteBRIDGE Plating and Posterior Fixation
NCT ID: NCT02068768
Last Updated: 2019-07-05
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
13 participants
OBSERVATIONAL
2013-07-15
2016-03-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective/Prospective Data Collection on the LDR ROIA Interbody Fusion Device With VerteBRIDGE Plating
NCT02104141
Retrospective/Prospective Data Collection on the LDR ROIC Interbody Fusion Device With VerteBRIDGE Plating
NCT02104167
Pivotal Study of rhBMP-2/ACS/LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease
NCT01491386
Pilot Study of rhBMP-2/ACS/LT-CAGE® for Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease
NCT01491373
A Pivotal Study of rhBMP-2/ACS/LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease
NCT01491425
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Operated Subjects
Subjects scheduled to receive an Avenue® L Interbody Fusion System (LDR Spine) for fusion of the lumbar spine from L2-S1
Avenue® L Interbody Fusion System (LDR Spine)
PEEK, intervertebral cage for interbody fusion of the lumbar spine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Avenue® L Interbody Fusion System (LDR Spine)
PEEK, intervertebral cage for interbody fusion of the lumbar spine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject must be skeletally mature at the time of surgery, i.e. the subject must be at least 21 years of age at the time of surgery
* Subject should have had a minimum of 6 months of non-operative treatment prior to surgery
* The placement of the Avenue L device must be a primary surgery
* Subject must be willing to sign the consent form and be able to return for all follow up visits.
Exclusion Criteria
* Subject is known to have substance or alcohol addictions
* Subject has lateral curvature of the spine (scoliosis, all types)
* Subject is a prisoner
* Subject is pregnant
* Subject has an active infection or sepsis at the time of surgery
* Subject has any neuromuscular disorder that would preclude accurate neurologic evaluations
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LDR Spine USA
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Spine and Orthopedics
Thornton, Colorado, United States
Orthopedic Surgery
Atlanta, Georgia, United States
Jersey Shore University Medical Center
Neptune City, New Jersey, United States
Southern New York Neurosurgical Group
Johnson City, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AveL100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.